We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Atrial Volume Predicts Cardiovascular Events

By HospiMedica staff writers
Posted on 16 Feb 2006
Left atrial volume (LAV) measurement is a promising and powerful tool for the evaluation and monitoring of patients with atrial fibrillation (AF), a new study suggests.

In this study, scientists at the Mayo Clinic (Rochester, MN, USA) conducted a long-range (median of 27 years) follow-up of 46 patients with lone AF. More...
Twenty-three of the patients (50%) experienced cardiovascular events. Cerebral infarction occurred in seven patients, myocardial infarction occurred in 11, and congestive heart failure in 16.

In an attempt to find out why a benign lone AF may evolve into a risk-associated AF, the Mayo group measured the changes in LAV. Patients with ‘uncomplicated' lone AF had normal atrial size, which remained unchanged for decades, signifying very low risk. Only when the atria became large, signifying increased atrial pressure, did stroke and heart failure begin to occur.

In a multivariate analysis, patients with an LAV index of 32 ml/m2 or greater had a significantly worse event-free survival. All the cerebral infarctions occurred in these patients. The results were published in the December 2005 edition of the European Heart Journal.

"Only atrial size, and not the duration and type of AF, were related to stroke and other risks,” said Dr. James B. Seward, an author of the study. "Physiological heart failure as depicted by atrial enlargement was the cause of AF-associated stroke and other risks.



Related Links:
Mayo Clinic

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.